All patients presented negative genetic testing, except for one patient disclosing a pathogenic granulin precursor (GRN) mutation and clinical features consistent with PD (asymmetric bradykinesia and rigidity with preserved cognitive function after 4-year of follow-up). The gene discussed is GRN; the disease is Parkinson disease.